China crackdowns on pharma firm over rabies vaccine scandal

China has put a hefty $1.3 billion penalty on a pharmaceutical firm following inconsistencies found in the company’s production and inspection records.

Changchun Changsheng Biotechnology, a firm based in northeast Jilin province which produced rabies vaccine has been accused by the China’s National Drug Administration (CNDA) of destroying records to conceal its misconduct, using expired ingredients, mixing different batches and failing to test them properly.

Authorities arrested the firm’s chairwoman and 14 other people. The failure of authorities to act immediately after finding inconsistencies had triggered a public outcry.

The company has now been stripped of its license and the production of the rabies vaccine has been stopped.



Please enter your comment!
Please enter your name here